Login / Signup

Quantifying and controlling the impact of regression to the mean on randomized controlled trials in epilepsy.

Daniel M GoldenholzEliana B GoldenholzTed J Kaptchuk
Published in: Epilepsia (2023)
The manipulation of eligibility criteria for RCTs has a predictable and important impact on RTM, and therefore on placebo response; the difference between drug and placebo was more easily detected. This in turn impacts trial efficacy and therefore cost. This study found dramatic improvements in efficacy and cost when baseline was not included in eligibility.
Keyphrases
  • phase iii
  • randomized controlled trial
  • clinical trial
  • double blind
  • study protocol
  • placebo controlled
  • emergency department
  • sensitive detection
  • living cells
  • quantum dots
  • electronic health record